Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Bladder Cancer
UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Search    Display results per page
Results 401 - 450 of 1726
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988 to 2004 - Abstract
Tuesday, 12 May 2009
Department of Urology, University of California, Davis Medical Center, Sacramento, California.
read more

A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219) - Abstract
Tuesday, 12 May 2009
University of California at Davis, Sacramento, California.
read more

Sex-Specific Hormone Receptors in Urothelial Carcinomas of the Human Urinary Bladder: A Comparative Analysis of Clinicopathological Features and Survival Outcomes According to Receptor Expression - Abstract
Tuesday, 12 May 2009
Department of Urology, Ministry of Health Yildirim Beyazit Diskapi Educational and Research Hospital, Ankara, Turkey.
read more

EGFR Pathway Polymorphisms and Bladder Cancer Susceptibility and Prognosis - Abstract
Tuesday, 12 May 2009
Department of Community and Family Medicine, Section of Biostatistics and Epidemiology, Dartmouth Medical School, Lebanon, NH 03756.
read more

Peritoneal Tuberculosis and Granulomatous Hepatitis Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guérin - Abstract
Monday, 11 May 2009
Department of Gastroenterology, Bakirkoy Training and Research Hospital, Istanbul, Turkey.
read more

Tuberculous Epididymitis Following Intravesical Bacillus Calmette-Guérin Immunotherapy - Abstract
Monday, 11 May 2009
Department of Urologic Sciences, University of British Columbia (Island Medical Program), Victoria, BC, Canada.
read more

Comparison of ImmunoCyt, UroVysion, and Urine Cytology in Detection of Recurrent Urothelial Carcinoma: A "Split-Sample" Study - Abstract
Monday, 11 May 2009
Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
read more

In Vivo Studies on the Availability and Toxicity of Antisense Oligonucleotides in Bladder Cancer - Abstract
Monday, 11 May 2009
Department of Urology, University of Lübeck, Lübeck, Germany.
read more

Beyond the Abstract - Diagnostic Accuracy of Transitional Cell Carcinoma on Multidetector Computerized Tomography Urography in Patients With Gross Hematuria
Friday, 08 May 2009
BERKELEY, CA (UroToday.com) - Our current study proves that multidetector computerized tomography urography (MDCTU) is sensitive and accurate for transitional cell carcinoma (TCC) of the urinary tract in hematuria patients.
Login to read more...

Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases - Abstract
Friday, 08 May 2009
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
read more

Recurrence at Three Months and High-Grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors - Abstract
Friday, 08 May 2009
Department of Urology, Hospital Universitario Puerto Real, Cádiz, Spain.
read more

Updated Results of Bladder-Sparing Trimodality Approach for Invasive Bladder Cancer - Abstract
Friday, 08 May 2009
Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain.
read more

The Role of Biotransformation Enzymes in the Development of Renal Injury and Urothelial Cancer Caused by Aristolochic Acid: Urgent Questions and Difficult Answers - Abstract
Tuesday, 05 May 2009
Department of Biochemistry, Faculty of Sciences, Charles University, Albertov 2030, Prague, Czech Republic.
read more

Laparoscopic Radical Cystectomy: Current Status, Outcomes, and Patient Selection - Abstract
Monday, 04 May 2009
Department of Urology, Center for Laparoscopic and Robotic Surgery, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
read more

AUA 2009 - Bladder Cancer: Superficial - Racial Differences in Treatment and Outcomes Among Patients with Early Stage Bladder Cancer - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study explored the extent to which disparities in mortality are attributable to the urologist among patients with early stage bladder cancer.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - Hexaminolevulinate Fluorescence Cystoscopy Improves Detection and Resection of Papillary Bladder Cancer Lesions and Reduces Early Recurrences - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study sought to compare fluorescence guided and white light cystoscopy in the detection of non-muscle invasive papillary bladder tumors, and to compare early recurrence rates following HAL or white light resection of identified tumors.
Login to read more...

AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Detection of Circulating Tumour Cells with the Cellsearch System® in Peripheral Blood from Patients with Advanced Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - The CellSearch System®(CSS) is a new automated, standardized enrichment and immunocytochemical detection system for circulating tumor cells (CTCs) in the peripheral blood.
Login to read more...

AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Significance of Distal Ureteral Margin at Radical Cystectomy for Urothelial Carcinoma - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - Patients undergoing radical cystectomy are at risk for upper tract recurrence.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - This study assessed the use of NMP22 to predict which high-risk superficial bladder cancer patients will have recurrence, progression or disease-related death and compared this to standard urine cytology.
Login to read more...

AUA 2009 - Bladder Cancer: Superficial - Intraoperative Stenting of the Upper Urinary Tract is not Necessary After Resection of the Ureteric Orifice During Transurethral Resection of the Bladder - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - These researchers evaluated the common practice of placing a double J stent when transurethral resection of a bladder tumor (TUR-B) includes resection of the ureteric orifice.
Login to read more...

AUA 2009 - A Review of AUA Clinical Guidelines on the Management of Non-Muscle Invasive Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - A panel on non-muscle invasive bladder cancer (NMIBC) was moderated by Dr. Mark Soloway.
Login to read more...

AUA 2009 - NMP22 is Predictive of Recurrence in High-Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, the authors suggests that NMP22 might be useful for predicting which patients will have future tumor recurrence but not progression or survival.
Login to read more...

AUA 2009 - Société Internationale d’Urologie (SIU) Lecture - Lymph Node Dissection in Urologic Cancers: Treatment or Staging Only - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Professor Joachim Thuroff discussed lymph node dissection (LND) in urologic cancers.
Login to read more...

AUA 2009 - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Poster
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - We assessed the use of urinary NMP22 to predict which high risk superficial UC patients will have recurrence, progression or disease related death and compared this to standard urine cytology.
Login to read more...

AUA 2009 - New Approaches to Management of Cancer Invasiveness: Personalized Therapy and Drug Discovery in Urologic Cancer - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Dan Theodorescu presented the concept of personalized cancer therapy.
Login to read more...

AUA 2009 - Bladder Cancer: Detection and Screening - Combinations of Several Urinary Tumour Markers Can Reduce Follow-up Cystoscopies in Transitional Cell Carcinoma Patients - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this presentation was to investigate if a combination of several tumor markers might be used to safely reduce the number of cystoscopies in patients with transitional cell carcinoma (TCC).
Login to read more...

AUA 2009 - Bladder Cancer: Detection and Screening - Molecular Tumor Marker Tests for Bladder Cancer Screening are Influenced by Various Confounders - Interim Data of the Prospective Study UroScreen - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation was on UroScreen, a prospective study for early diagnosis of bladder cancer in 1,772 chemical workers formerly exposed to aromatic amines.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Quantification of Sunitinib's Antitumor Effects in a Localized Orthotopic Bladder Cancer Model - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This study reported on the effects of sunitinib on tumor growth rate, tumor volume, and vascular endothelial growth factor (VEGF) receptor (VEGFR2) expression in an orthotopic mouse bladder cancer model.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation reported on the effect of the mTOR inhibitor everolimus (RAD001) on human bladder cancer cells in vitro and in vivo.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Clinical Significance of False Positive Mucosa by Photodynamic Diagnosis-Possible Existence of Premalignant Genomic Alterations - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Photodynamic diagnosis (PDD) by the fluorescence cystoscopy has become a novel tool not only for decreasing the recurrence in non-invasive bladder cancer.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Combinational p53 and Pten Inactivation Promotes Invasive Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This group of investigators from Columbia University have previously revealed distinct genotypic and phenotypic patterns associated with non muscle-invasive versus muscle-invasive bladder cancer.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - Absence of CD44 Expression is an Independent Predictor of Poor Outcome for Patients with Urothelial Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation reported on CD44 expression in bladder cancer and its association with survival.
Login to read more...

AUA 2009 - Bladder Cancer: Basic Research - The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This group of investigators sought to determine the frequency of fibroblast growth factor receptor 3 (FGFR3) mutations in a group of primary pT1 bladder cancer tumors (BC) and correlate the FGFR3 mutation to various histo-pathological variables.
Login to read more...

AUA 2009 - Combinations of Several Urinary Tumour Markers Can Reduce Follow-up Cystoscopies in Transitional Cell Carcinoma Patients - Poster
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to investigate if a combination of several tumour markers might be used to safely reduce the number of cystoscopies in transitional cell carcinoma (TCC) patients.
Login to read more...

AUA 2009 - State-of-the-Art Lecture – Enterocystoplasty: What is the Risk of Malignancy? - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Risk of malignancy exists after augmentation.
Login to read more...

AUA 2009 - Unnecessary Consultation and Evaluation in Patient with Pseudohematuria: An Analysis of Referral Patterns for Asymptomatic Hematuria - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This report suggests that many patients with asymptomatic hematuria undergo unnecessary consultation and evaluation.
Login to read more...

AUA 2009 - Veterans with Nonmuscle-Invasive Bladder Cancer Report Worse HRQOL than Private Patients - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. Sai Munjampalli et al. presented preliminary data from an ongoing study suggesting that veterans have poorer health-related quality of life (HRQOL) than private patients.
Login to read more...

AUA 2009 - Myoblasts Can Form New Muscle Tissue and Induce Angio-and Neurogenisis - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. Hannes Strasser presented work from Austria which suggests that myoblasts have the capacity to form new muscle tissue in vitro and induce angiogenesis and neurogeneis.
Login to read more...

AUA 2009 - Urothelial Cancer: Upper Tract Tumors - Patterns and Predictors of Urothelial Recurrence Following Nephroureterectomy for Upper Tract Tumors - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - These authors report on the incidence, clinicopathologic features, and predictors of recurrent tumors after nephroureterectomy (NU) for upper tract urothelial carcinoma (UTUC) in patients with no prior history of bladder cancer.
Login to read more...

AUA 2009 - Urothelial Cancer: Upper Tract Tumors - Troubling Outcomes from a Population Level Analysis of Surgery for Upper Tract Urothelial Carcinoma - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to review the surgical management of upper tract urothelial carcinoma (UTUC) on a population level to determine if sub-optimal surgical technique is associated with an adverse prognosis.
Login to read more...

AUA 2009 - Urothelial Cancer: Surgical Therapy - BMI and Age are Independent Predictors of Postoperative Ileus Following Radical Cystectomy with Pelvic Lymphadenectomy - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to identify potential preoperative features that would aid in the identification of patients at highest risk for developing post-operative ileus.
Login to read more...

AUA 2009 - Urothelial Cancer: Surgical Therapy - Removal of at Least 8 Nodes Improves Cancer Specific Survival in Non Metastatic Patients with Upper Tract Urothelial Carcinoma - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This large multi-institutional research consortium sought to establish a minimum number of lymph nodes (LN) that should be removed to improve cancer-specific survival (CSS) in patients with urothelial carcinoma of the upper urinary tract (UTUC) managed with radical nephroureterectomy (RNU) and lymph node dissection.
Login to read more...

AUA 2009 - Bladder & Urethra: Anatomy, Physiology and Pharmacology - Myoblasts Can Form New Muscle Tissue and Induce Angio-And Neurogenesis - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Much focus is on the ability of stem cells to differentiate into other tissue types.
Login to read more...

AUA 2009 - Bladder Cancer: General & Epidemiological Trends & Socioeconomics: Unnecessary Consultation and Evaluation in Patient with Pseudohematuria: An Analysis of Referral Patterns for Asymptomatic Hematuria - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Screening for bladder cancer is often practiced by Primary Care Providers (PCP’s), although it is not recommended by major health care organizations.
Login to read more...

AUA 2009 - Ethnic Differences in Bladder Cancer Survival - Session Highlights
Sunday, 26 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. David Yee, et al. from New York studied the SEER database and showed that African Americans have an increased rate of death from bladder cancer compared to whites, Hispanics and Asian Pacific Americans.
Login to read more...

AUA 2009 - Delays in Bladder Cancer Diagnosis and Survival - Session Highlights
Sunday, 26 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report from University of Michigan investigators, the authors added to the body of literature which suggests that a delay in diagnosis leads to increase risk of bladder cancer death.
Login to read more...

AUA 2009 - Intravesical BCG Therapy, Lessons Learned from History and Clinical Investigation - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Harry Herr of the Memorial Sloan-Kettering Cancer Center was honored with the Whitmore medal and his lecture was titled “Intravesical BCG Therapy, Lessons Learned from History and Clinical Investigation.”
Login to read more...

AUA 2009 - Current Status of Node Dissection in Urologic Cancer: T1-3, N0 Bladder Cancer - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Peter Clark of Vanderbilt University opened his presentation by defining lymph node (LN) density as the number of positive lymph nodes divided by the number removed.
Login to read more...

AUA 2009 - Beyond the AUA Guidelines for the Management of Non-Muscle Invasive Bladder Cancer - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - The group of panelists, led by Dr. Sam Chang, first discussed recurrent CIS after induction BCG.
Login to read more...

Transitional Cell Carcinoma of the Bladder in Adolescents: A Diagnosis to Bear in Mind - Abstract
Friday, 24 April 2009
Sección Urología Pediátrica, Servicio de Cirugía Pediátrica, Departamento de Pediatría, Hospital Italiano, Buenos Aires.
read more








Exclusive!

Interview on Clinical Practice Experience with NMP22

Meet the Expert

Meet the Expert - Mark S. Soloway

Meet the Expert - Ihor S. Sawczuk

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.



Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- Beyond the Abstract

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- Editorial

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- Editorial

ImageTherapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

- BJUI Mini Reviews

Image

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- UroToday International Journal

ImageTwo Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

- BJUI Mini Reviews

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- Beyond the Abstract

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- Editorial

Image

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- UroToday International Journal

Radiation Therapy for Prostate Cancer Increases Subsequent Risk of Bladder and Rectal Cancer: A Population Based Cohort Study

- Editorial

Image

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- UroToday International Journal

ImageInvestigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- UroToday International Journal

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- Editorial

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- Editorial

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- Editorial - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- Editorial - Editor's Pick

ImageBladder Cancer and the Aluminium Industry: A Review

- BJUI Mini Reviews

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- Beyond the Abstract

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- Beyond the Abstract

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- Beyond the Abstract

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- Beyond the Abstract

Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry

- Beyond the Abstract

ImageInvasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

- BJUI Mini Reviews

Podcast - San Francisco Firefighters and Bladder Cancer Screening

- Podcast

ImagePredicting Survival After Radical Cystectomy for Bladder Cancer

- BJUI Mini Reviews







Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay

- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?

- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer

- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study

- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay

- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group




Bladder Cancer in Conferences


ImageAmerican Society of Clinical Oncology (ASCO) 2009 Annual Meeting

- View Bladder Cancer Session Highlights
ImageAmerican Urological Association (AUA) 2009 Annual Meeting

- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
Image10 Tips for Non-Muscle Invasive Bladder Cancer

- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

ImageSociety of Urologic Oncology (SUO) 9th Annual Winter Meeting

- View Bladder Cancer Session Highlights

ImageRobot Assisted Radical Cystectomy: Is it Ready for Prime Time?

- Session Highlight from AUA Western Section 2008

ImageBladder Cancer Cytology and Markers in Diagnosis and Assessment

- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?

- Slide Presentation from the 2008 AUA NY Section Meeting

ImageNon-Muscle Invasive Transitional Cell Carcinoma

- Slide Presentation from the 2008 Masters in Urology Conference

American Society of Clinical Oncology 44th Annual Meeting

- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting

- Bladder Cancer Session Highlights

ImageEngineering and Urology Society 23rd Annual Meeting

- Bladder Cancer Abstracts

ImageEuropean Association of Urology 23rd Annual EAU Congress

- Bladder Cancer Session Highlights

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 401 - 450 of 1726

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Media and Publisher

Advertising Rates
Reprints

Working with Industry

Case Studies
Sponsorship Opportunities

Bladder Cancer
Sponsored By